Sofie Traynor

825 total citations
18 papers, 537 citations indexed

About

Sofie Traynor is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sofie Traynor has authored 18 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in Sofie Traynor's work include Genomics and Chromatin Dynamics (7 papers), Epigenetics and DNA Methylation (5 papers) and Immunotherapy and Immune Responses (4 papers). Sofie Traynor is often cited by papers focused on Genomics and Chromatin Dynamics (7 papers), Epigenetics and DNA Methylation (5 papers) and Immunotherapy and Immune Responses (4 papers). Sofie Traynor collaborates with scholars based in Denmark, United States and Australia. Sofie Traynor's co-authors include Susanne Mandrup, Ronni Nielsen, Rasmus Siersbæk, Atefeh Rabiee, Ole N. Jensen, Jesper Grud Skat Madsen, Biola M. Javierre, Peter Fraser, Anne Loft and Adelina Rogowska-Wrzesińska and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Molecular Cell.

In The Last Decade

Sofie Traynor

18 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofie Traynor Denmark 9 444 81 68 62 59 18 537
Kalliopi Stratigi Greece 11 316 0.7× 45 0.6× 66 1.0× 46 0.7× 55 0.9× 17 413
Jinmi Choi South Korea 12 515 1.2× 35 0.4× 38 0.6× 57 0.9× 91 1.5× 17 590
Ei-ichi Takahashi Japan 9 284 0.6× 56 0.7× 34 0.5× 123 2.0× 44 0.7× 9 420
Ka Sin Mak Australia 11 245 0.6× 44 0.5× 50 0.7× 65 1.0× 37 0.6× 11 348
Andrew Melvin United Kingdom 6 355 0.8× 36 0.4× 68 1.0× 52 0.8× 234 4.0× 7 519
Ashley Cass United States 8 319 0.7× 16 0.2× 60 0.9× 48 0.8× 105 1.8× 13 429
Anne Zirkel Germany 11 436 1.0× 67 0.8× 57 0.8× 34 0.5× 139 2.4× 13 549
Wenbing Xie China 13 636 1.4× 65 0.8× 55 0.8× 70 1.1× 109 1.8× 19 739
Roza Berhanu Lemma Norway 5 280 0.6× 14 0.2× 48 0.7× 43 0.7× 64 1.1× 9 417
Takahiro Naiki Japan 9 584 1.3× 62 0.8× 39 0.6× 64 1.0× 148 2.5× 10 686

Countries citing papers authored by Sofie Traynor

Since Specialization
Citations

This map shows the geographic impact of Sofie Traynor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Traynor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Traynor more than expected).

Fields of papers citing papers by Sofie Traynor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Traynor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Traynor. The network helps show where Sofie Traynor may publish in the future.

Co-authorship network of co-authors of Sofie Traynor

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Traynor. A scholar is included among the top collaborators of Sofie Traynor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Traynor. Sofie Traynor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ehmsen, Sidse, Sofie Traynor, N I Nissen, et al.. (2025). RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer. Frontiers in Oncology. 14. 1497093–1497093. 1 indexed citations
2.
Traynor, Sofie, Christina Dahl, Mette Stæhr, et al.. (2025). Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition. Journal of Experimental & Clinical Cancer Research. 44(1). 21–21. 3 indexed citations
3.
4.
Traynor, Sofie, Yaseelan Palarasah, Christina B. Pedersen, et al.. (2024). Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer. Journal for ImmunoTherapy of Cancer. 12(6). e008759–e008759. 9 indexed citations
5.
Holmström, Morten Orebo, Morten Andersen, Sofie Traynor, et al.. (2023). Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow. Frontiers in Immunology. 14. 1240678–1240678. 5 indexed citations
7.
Traynor, Sofie, et al.. (2022). SSX addiction in melanoma propagates tumor growth and metastasis. Frontiers in Oncology. 12. 998000–998000. 2 indexed citations
8.
Traynor, Sofie, et al.. (2022). ZBED1 Regulates Genes Important for Multiple Biological Processes of the Placenta. Genes. 13(1). 133–133. 3 indexed citations
9.
Gjerstorff, Morten F., et al.. (2022). PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer. Cancers. 14(24). 6153–6153. 3 indexed citations
10.
Traynor, Sofie, Mette Stæhr, Mikkel G. Terp, et al.. (2021). The Cancer/Testis Antigen Gene VCX2 Is Rarely Expressed in Malignancies but Can Be Epigenetically Activated Using DNA Methyltransferase and Histone Deacetylase Inhibitors. Frontiers in Oncology. 10. 584024–584024. 16 indexed citations
11.
Traynor, Sofie, Morten Frendø Ebbesen, Carsten Bøcker Pedersen, et al.. (2021). SSX2 promotes the formation of a novel type of intranuclear lamin bodies. The International Journal of Biochemistry & Cell Biology. 142. 106121–106121. 1 indexed citations
12.
Madsen, Jesper Grud Skat, Maria S. Madsen, Alexander Rauch, et al.. (2020). Highly interconnected enhancer communities control lineage-determining genes in human mesenchymal stem cells. Nature Genetics. 52(11). 1227–1238. 53 indexed citations
13.
Ormhøj, Maria, et al.. (2020). Augmenting engineered T-cell strategies in solid cancers through epigenetic priming. Cancer Immunology Immunotherapy. 69(11). 2169–2178. 6 indexed citations
14.
Traynor, Sofie, Niels Erik Møllegaard, Mikkel Girke Jørgensen, et al.. (2019). Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins. Nucleic Acids Research. 47(13). 6668–6684. 17 indexed citations
15.
Traynor, Sofie, et al.. (2018). Human DREF/ZBED1 is a nuclear protein widely expressed in multiple cell types derived from all three primary germ layers. PLoS ONE. 13(10). e0205461–e0205461. 6 indexed citations
16.
Siersbæk, Rasmus, Jesper Grud Skat Madsen, Biola M. Javierre, et al.. (2017). Dynamic Rewiring of Promoter-Anchored Chromatin Loops during Adipocyte Differentiation. Molecular Cell. 66(3). 420–435.e5. 155 indexed citations
17.
Siersbæk, Rasmus, Atefeh Rabiee, Ronni Nielsen, et al.. (2014). Transcription Factor Cooperativity in Early Adipogenic Hotspots and Super-Enhancers. Cell Reports. 7(5). 1443–1455. 180 indexed citations
18.
Siersbæk, Rasmus, Songjoon Baek, Atefeh Rabiee, et al.. (2014). Molecular Architecture of Transcription Factor Hotspots in Early Adipogenesis. Cell Reports. 7(5). 1434–1442. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026